Restoration of nitric oxide function in human hyperlipidaemia, congestive heart failure and liver cirrhosis

Clinical and Experimental Pharmacology and Physiology

Volumn 25, Issue 9, 1998, Pages 645-652

  Chin Dusting, Jaye P F ^a,b   Kaye, David M ^a  

^a ALFRED HOSPITAL   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Cirrhosis; Congestive heart failure; Endothelium; Human; Hypercholesterolaemia; Nitric oxide

Indexed keywords

ANTIBIOTIC AGENT; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC OXIDE; POLYUNSATURATED FATTY ACID;

CONGESTIVE HEART FAILURE; DIET SUPPLEMENTATION; ENDOTHELIUM; EXERCISE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIVER CIRRHOSIS; REVIEW;

EID: 0031690993     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1998.tb02271.x     Document Type: Review

References (101)

1. Rees D, Palmer R, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl Acad. Sci. USA 1989; 86: 3375-8.
2. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide peripheral arteriolar tone in man. Lancet 1989; ii: 997-1000.
3. Haynes WG, Noon JP, Walker BR, Webb DJ. L-NMMA increases blood pressure in man. Lancet 1993; 342: 931-2.
4. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolemia. Lancet 1992; 340: 1430-2.
5. Chin JPF, Dart AM. Therapeutic restoration of endothelial function in hypercholesterolaemic subjects: Effect of fish oils. Clin. Exp. Pharmacol. Physiol. 1994; 21: 749-55.
6. Kubo S, Rector TS, Bank A, Williams P, Heifetz S. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991; 84: 1589-96.
7. Chin-Dusting J, Kaye D, Lefkovits J, Wong J, Bergin P, Jennings G. Dietary supplementation with L-arginine fails to restore endothelial function in forearm resistance arteries of patients with severe heart failure. J. Am. Coll. Cardiol. 1996; 27: 1207-13.
8. Laffi G, Foschi M, Masini E et al. Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. Hepatology 1995; 22: 1666-73.
9. Winlaw D, Smythe G, Keogh A, Schyvens C, Spratt P, Macdonald P. Increased nitric oxide production in heart failure. Lancet 1994; 344: 373-4.
10. Nathan C, Xie Q-w. Nitric oxide synthases: Roles, tolls and controls. Cell 1994; 78: 915-16.
11. Griffith O, Stuehr D. Nitric oxide synthases: Properties and catalytic mechanism. Annu. Rev. Physiol. 1995; 57: 737-69.
12. Gross S, Wolin M. Nitric oxide: Pathophysiology mechanisms. Annu. Rev. Physiol. 1995; 57: 737-69.
13. White M. The transport of cationic amino acids across the plasma membrane of mammalian cells. Biochim. Biophys. Acta 1985; 822: 355-74.
14. Greene B, Pacitti A, Souba W. Characterisation of L-arginine transport by pulmonary artery endothelial cells. Am. J. Physiol. 1993; 264: L351-6.
15. Closs E, Albritton L, Kim J. Identification of a low affinity, high capacity transporter of cationic amino acids in mouse liver. J. Biol. Chem. 1993; 268: 7538-44.
16. Closs E, Lyons C, Kelly C, Cunningham J. Characterization of the third member of the MCAT family of cationic amino acid transporters: Identification of a domain that determines the transport properties of the MCAT proteins. J. Biol. Chem. 1993; 268: 20796-800.
17. Durante W, Liao L, Schafer A. Differential regulation of L-arginine transport and inducible NOS in cultured vascular smooth muscle cells. Am. J. Physiol. 1995; 268: H1158-64.
18. Shepherd J, Katusic Z. Endothelium-derived vasoactive factors: I. Endothelium dependent relaxation. Hypertension 1991; 18(Suppl. III): 76-85.
19. Kaye D, Wiviott S, Balligand J-L, Simmons W, Smith T, Kelly R. Frequency-dependent activation of a constitutive nitric oxide synthase and regulation of contractile function in adult rat ventricular myocytes. Circ. Res. 1996; 78: 217-24.
20. Umans J, Levi R. Nitric oxide in the regulation of blood flow and arterial pressure. Annu. Rev. Physiol. 1995; 57: 771-90.
21. Celermajer D, Sorensen K, Gooch V et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-15.
22. Seiler C, Hess O, Buechi M, Suter T, Krayerbuehl H. Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries. Circulation 1993; 88: 2139-48.
23. Drexler H, Zeiher AM. Endothelial function in human coronary arteries in vivo. Focus on hypercholesterolemia. Hypertension 1991; 18: II-90-9.
24. Lewis T, Dart A, Chin-Dusting J. Non-specific inhibition by human lipoproteins of endothelium dependent relaxation in rat aorta may be attributed to lipoprotein phospholipids. Cardiovasc. Res. 1997; 34: 590-6.
25. Plane F, Bruckdorfer R, Kerr P, Steuer A, Jacobs M. Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta. Br. J. Pharmacol. 1992; 105: 216-22.
26. Shimokawa H, Flavahan N, Vanhoutte P. Loss of endothelial pertussis-toxin G protein function in atherosclerotic porcine coronary arteries. Circulation 1991; 83: 652-60.
27. i proteins by low density lipoprotein attenuates bradykinin-stimulated release of endothelial-derived nitric oxide. J. Biol. Chem. 1994; 269: 12987-92.
28. Liao J, Shin W, Lee W, Clark S. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J. Biol. Chem. 1995; 270: 319-24.
29. Chin JH, Azhar S, Hoffman BB. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J. Clin. Invest. 1992; 89: 10-18.
30. Leung W, Lau C-P, Wong C-K. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemic patients. Lancet 1993; 341: 1496-500.
31. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL apharesis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 1997; 95: 76-82.
32. Goode G, Heagerty A. In vitro responses of human peripheral small arteries in hypercholesterolemia and effects of therapy. Circulation 1995; 91: 2898-903.
33. Lewis TL, Dart AM, Chin-Dusting JPF. Responses to endothelium dependent agonists in subcutaneous arteries excised from hypercholesterolaemic humans. Br. J. Pharmacol. 1998; 124: 222-8.
34. Heitzer T, Yla-Herttuala S, Luoma J et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 1996; 93: 1346-53.
35. Quyyumi A, Mulcahy D, Andrews N, Husain S, Panza J, Cannon RI. Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia. Comparison of acetylcholine and substance P. Circulation 1997; 95: 104-10.
36. Flavahan N. Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation 1992; 85: 1927-38.
37. Preik M, Kelm M, Schoebel F, Schottenfeld Y, Leschke M, Strauer B. Selective impairment of nitric oxide dependent vasodilation in young adults with hypercholesterolemia. J. Cardiovasc. Risk 1996; 3: 465-71.
38. Bedarida G, Bushell E, Haefeli W, Blaschkke T, Hoffman B. Responsiveness to bradykinin in veins of hypercholesterolaemic humans. Circulation 1993; 88: 2754-61.
39. Vogel R, Corretti M, Plotnick G. Effect of a single high-fat meal on endothelial function in healthy subjects. Am. J. Cardiol. 1997; 79: 350-4.
40. Tsao P, Lewis N, Alpert S, Cooke J. Exposure to shear stress alters endothelial adhesiveness: Role of nitric oxide. Circulation 1995; 92: 3513-19.
41. Harrison DG, Armstrong ML, Freiman PC, Heistad DD. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J. Clin. Invest. 1987; 80: 1808-11.
42. Stroes E, Koomans H, de Bruin T, Rabelink T. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet 1995; 346: 467-71.
43. O'Driscoll G, Green D, Taylor R. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 1997; 95: 1126-31.
44. Andrews T, Raby K, Barry J et al. Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease. Circulation 1997; 95: 324-8.
45. Mancini G, Henry G, Macaya C et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 1996; 94: 258-65.
46. Pitt B. The potential use of angiotensin-converting enzyme inhibitors in patients with hyperlipidaemia. Am. J. Cardiol. 1997; 79: 24-8.
47. Palmer R, Ashton D, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-6.
48. Gold ME, Bush PA, Ignarro LJ. Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation. Biochem. Biophys. Res. Commun. 1989: 164: 714-21.
49. Girerd X, Hirsch A, Cooke J, Dzau V, Creager M. L-Arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ. Res. 1990; 1990: 1301-8.
50. Tsao PS, Theilmeier G, Singer AH, Leung LL-K, Cooke JP. L-Arginine attenuates platelet reactivity in hypercholesterolemic rabbits. Arterioscler. Thromb. 1994; 14: 1529-33.
51. Wolf A, Zalpour C, Theilmeier G, Wang BY, Ma A, Anderson B. Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. J. Am. Coll. Cardiol. 1997; 29: 479-85.
52. Adams M, Jessup W, Hailstones D, Celermajer D. L-Arginine reduces human monocyte adhesion to vascular endothelium and endothelial expression of cell adhesion molecules. Circulation 1997; 95: 662-8.
53. Jeserich M, Munzel T, Just H, Drexler H. Reduced plasma L-arginine in hypercholesterolemia. Lancet 1992; 339: 561.
54. Pasini F, Frigerio C, De Giorgi L, Blardi P, Di Perri T. L-Arginine plasma concentrations in hypercholesterolemia. Lancet 1992; 340: 549.
55. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J. Clin. Invest. 1992; 90: 1248-53.
56. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991; 338: 1546-60.
57. Chin-Dusting J, Alexander C, Arnold P, Hodgson W, Lux A, Jennings G. Effects of in vivo and in vitro L-arginine supplementation on healthy human vessels. J. Cardiovasc. Pharmacol. 1996; 28: 158-66.
58. Huk I, Nanobashvili J, Neumayer C et al. L-Arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation 1997; 96: 667-75.
59. Pritchard KJ, Groszek L, Smalley D et al. Native low-density lipoprotein increases endothelial cell synthase generation of superoxide anion. Circ. Res. 1995; 77: 510-18.
60. Chin J. Marine Oils and Cardiovascular Reactivity. Prostagland. Leukotriene Essent. Fatty Acids 1994; 50: 211-22.
61. Chin J, Dart A. How do fish oils affect vascular function? Clin. Exp. Pharmacol. Physiol. 1995; 22: 71-81.
62. Chin JPF, Gust AP, Dart AM. Indomethacin inhibits the effects of dietary supplementation with marine oils on vasoconstriction of human forearm resistance vessels in vivo. J. Hypertens. 1993; 11: 1229-34.
63. Vekshtein V, Yeung A, Vita J. Fish oil improves endothelium-dependent relaxation in patients with coronary artery disease. Circulation 1989; 80 (Suppl. II): 434.
64. Fleischhauer F, Yan W-D, Fischell T. Fish oil improves endothelium-dependent coronary vasodilation in heart transplant recipients. J. Am. Coll. Cardiol. 1993; 21: 982-9.
65. Chowienczyk P, Watts G, Cockcroft J, Brett S, Ritter J. Sex differences in endothelial function in normal and hypercholesterolaemic subjects. Lancet 1994; 344: 305-6.
66. Chin J, Dart A. Endothelial dysfunction in hypercholesterolaemic post-menopausal women. Lancet 1994; 344: 949.
67. Collins P, Rosano GM, Sarrel PM et al. 17Beta-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995; 92: 24-30.
68. Lieberman EH, Gerhard MD, Uehata A et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann. Intern. Med. 1994; 121: 936-41.
69. McCrohon JA, Adams MR, McCredie RJ, Robinson JTC, Keech AC, Celermajer DS. Hormone replacement therapy is associated with improved endothelial function in post-menopausal women. Circulation 1996; 94 (Suppl.): 1-462.
70. Ting H, Timimi F, Haley E, Roddy M, Ganz P, Creager M. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation 1997; 95: 2617-22.
71. Levine G, Frei B, Koulouris S, Gerhard M, Keaney JJ, Vita J. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996; 93: 1107-13.
72. Stroes E, Kastelein J, Cosentino F et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J. Clin. Invest. 1997; 99: 41-6.
73. Zelis R, Mason D, Braunwald E. A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. J. Clin. Invest. 1968; 47: 960-70.
74. Zelis R, Longhurst J, Capone R, Mason D. A comparison of regional blood flow and oxygen utilization during dynamic forearm exercise in normal subjects and patients with congestive heart failure. Circulation 1974; 50: 137-43.
75. Wilson J, Wiener D, Fink L, Ferraro N. Vasodilatory behaviour of skeletal muscle arterioles in patients with nonedematous chronic heart failure. Circulation 1986; 74: 775-9.
76. Kaiser L, Spickard R, Olivier N. Heart failure depresses endothelium-dependent responses in canine femoral artery. Am. J. Physiol. 1989; 256: H962-7.
77. Kaye D, Jennings G, Angus J. Evidence for impaired endothelium dependent vasodilation in experimental left ventricular dysfunction. Clin. Exp. Pharmacol. Physiol. 1994; 21: 709-19.
78. Angus J, Ferrier C, Sudhir K, Kaye D, Jennings G. Impaired contraction and relaxation in skin resistance arteries from patients with congestive heart failure. Cardiovasc. Res. 1993; 27: 204-10.
79. Hirooka Y, Imaizumi T, Harada S et al. Endothelium-dependent forearm vasodilation to acetylcholine but not to substance Pis impaired in patients with heart failure. J. Cardiovasc. Pharmacol. 1992; 20: S221-5.
80. Angus JA, Lew MJ. Interpretation of the acetylcholine test of endothelial cell dysfunction in hypertension. J. Hypertens. 1992; 10: S179-86.
81. Wrobleski H, Kastrup J, Norgaard T, Mortensen S, Haunso S. Evidence of increased microvascular resistance and arteriolar hyalinosis in skin in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am. J. Cardiol. 1992; 69: 769-74.
82. O'Murchu B, Miller VM, Perrella MA, Burnett JCJ. Increased production of nitric oxide in coronary arteries during heart failure. J. Clin. Invest. 1994; 93: 165-71.
83. Smith C, Sum D, Hoegler C et al. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ. Res. 1996; 78: 58-64.
84. Haywood G, Tsao P, von der Leyen H et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation 1996; 93: 1087-95.
85. Habib F, Dutka D, Crossman D, Oakley C, Cleland J. Enhanced basal nitric oxide production in heart failure: Another failed counter-regulatory vasodilator mechanism? Lancet 1994; 344: 371-3.
86. De Belder A, Radomski M. Why H et al. Nitric oxide synthase activities in human myocardium. Lancet 1993; 341: 84-5.
87. Finkel M, Oddis C, Jacob T, Watkins S, Hattler B, Simmons R. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1996; 257: 387-9.
88. Kaye DM, Chin-Dusting J, Esler MD, Jennings GL. The failing heart does not release nitrogen oxides. Life Sci. 1998; 62: 883-7.
89. Bernstein R, Zhao G, Xu X, Forfia P, Ochoa M, Hintze T. NOx accumulation in plasma during pacing induced heart failure in conscious dogs is due to reduced renal function not increased NO production. Circulation 1996; 94 (Suppl. I): 1-658.
90. Nakamura M, Funakoshi T, Arakawa N, Yoshida H, Makita S, Hiramaori K. Effect of angiotensin converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure. J. Am. Coll. Cardiol. 1994; 93: 210-14.
91. Hirooka Y, Imaizumi T, Tagawa T et al. Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure. Circulation 1994; 90: 658-68.
92. Prior D, Jennings G, Bergin P, Chin-Dusting J. Single dose oral L-arginine improves endothelial dysfunction in congestive heart failure. J. Med. 1997; 27: 97.
93. Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation 1996; 93: 210-14.
94. Llach J, Gines P, Arroyo V. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988; 94: 482-7.
95. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: A role for nitric oxide? Lancet 1991; 337: 776-8.
96. Guarner C, Soriano G, Tomas A et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: Relationship to endotoxemia. Hepatology 1993; 18: 1139-13.
97. Matsumoto A, Ogura K, Hirata Y et al. Increased nitric oxide in the exhaled air of patients with decompensated liver cirrhosis. Ann. Intern. Med. 1995; 123: 110-13.
98. Ryan J, Jennings G, Dudley F, Chin-Dusting J. Smooth muscle derived nitric oxide is elevated in isolated forearm veins in human alcoholic cirrhosis. Clin. Sci. 1996; 91: 23-8.
99. Chin-Dusting J, Rasaratnam B, Dudley F, Jennings G. Bacterial endotoxins induce nitric oxide synthase in patients with liver cirrhosis. Circulation 1996; 94 (Suppl.): 1-147.
100. Sieber CC, Lopez-Talavera JC, Groszmann RJ. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivily in ascitic cirrhotic rats. Gastroenterology 1993; 104: 1750-4.
101. Chin-Dusting JPF, Rasaratnam B, Jennings GLR, Dudley FJ. Effect of fluoroquinolone on the enhanced nitric oxide-induced peripheral vasodilation seen in cirrhosis. Ann. Intern. Med. 1997; 127: 985-8.